Request for Covid-19 Impact Assessment of this Report
Dermatology devices help in diagnosing and treatment of skin disorders. These devices can be used for skin biopsy, cryosurgery, topical chemotherapy, photodynamic therapy, Mohs micrographic surgery, electrodessication, and curettage. There are various skin disorders, which include psoriasis, eczema, acne, rosacea, ichthyosis, vitiligo, hives, seborrheic dermatitis, and other skin disorders. Skin disorders vary in symptoms and severity. In addition, these can be temporary or permanent, and may be painless or painful. Some of the skin disorders have situational causes while others may be genetic. Some skin conditions are minor and others can be life-threatening.
Increase in prevalence of diseases that requires surgical treatment, especially minimally invasive surgery (MIS) would help the dermatology devices market to gain traction in the coming years. Furthermore, surge in prevalence of skin disorders, which require dermatology devices for management of the condition, is anticipated to propel the market to generate higher revenue shares. Increase in prevalence of conditions, such as psoriasis, acne, and other skin disorders, is anticipated to help the market generate higher revenues during the forecast period. Rise in healthcare spending, which can be used for treatment of skin conditions would help the market to gain traction during the forecast period.
The global dermatology devices market is segmented on the basis of product type, application, end user, and region. On the basis of product type, the market is categorized into diagnostic devices and treatment devices. In addition, diagnostics devices segment is further divided into imaging devices, dermatoscope, and microscope. Furthermore, treatment devices segment is categorized into electrosurgical, cryotherapy, and laser. By application, it is classified into skin cancer diagnosis, psoriasis, skin rejuvenation, and warts. By end user, it is bifurcated into hospitals, clinics and others. Region-wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA
KEY BENEFITS FOR STAKEHOLDERS
This report provides a detailed quantitative analysis of the current market trends and future estimations from 2020 to 2030, which assists to identify the prevailing market opportunities.
An in-depth analysis of various regions is anticipated to provide a detailed understanding of the current trends to enable stakeholders to formulate region-specific plans.
A comprehensive analysis of the factors that drive and restrain the growth of the hemodialysis and peritoneal dialysis market is provided.
An extensive analysis of various regions provides insights that allow companies to strategically plan their business moves.
KEY MARKET SEGMENTS
By Product Type
o Diagnostic Devices
Imaging devices
Dermatoscopes
Microscopes
o Treatment Devices
Electrosurgical devices
Cryotherapy devices
Laser devices
By Application Type
o Skin cancer diagnosis
o Psoriasis
o Skin rejuvenation
o Warts
By End User Type
o Hospitals
o Clinics
o others
By Region
o North America
U.S.
Canada
Mexico
o Europe
Germany
UK
France
Italy
Spain
Rest of Europe
o Asia-Pacific
Japan
China
India
Australia
South Korea
Rest of Asia-Pacific
o LAMEA
Brazil
Saudi Arabia
South Africa
Rest of LAMEA
KEY MARKET PLAYERS
• Alma Lasers Ltd.
• Ambicare Health Ltd
• Bausch Health Companies Inc.
• Candela Laser Corp
• Canfield Scientific, Inc
• Carl Zeiss Meditec Ag
• Cutera, Inc.
• Cynosure, Inc.
• Heine Optotechnik
• Lumenis Ltd.
1.1.Report description
1.2.Key benefits for stakeholders
1.3.Key market segments
1.3.1.List of key players profiled in the report
1.4.Research methodology
1.4.1.Secondary research
1.4.2.Primary research
1.4.3.Analyst tools and models
CHAPTER 2:EXECUTIVE SUMMARY
2.1.Key findings of the study
2.2.CXO perspective
CHAPTER 3:MARKET LANDSCAPE
3.1.Market definition and scope
3.2.Key findings
3.2.1.Top investment pockets
3.2.2.Top winning strategies
3.3.Porter’s five force analysis
3.4.Top player positioning, 2020
3.5.Market dynamics
3.5.1.Drivers
3.5.1.1.Increase in prevalence of skin diseases
3.5.1.2.Surge in preference of minimally invasive instruments
3.5.1.3.Increase in prevalence of aging associated diseases
3.5.2.Restraint
3.5.2.1.Higher price of dermatology devices
3.5.3.Opportunities
3.5.3.1.Growth potential in emerging economies
3.5.4.Impact analysis
3.6.COVID-19 impact analysis on dermatology devices market
CHAPTER 4:DERMATOLOGY DEVICES MARKET, BY PRODUCT TYPE
4.1.Overview
4.1.1.Market size and forecast
4.2.Diagnostic devices
4.2.1.Key market trends, growth factors, and opportunities
4.2.2.Market size and forecast, by region
4.2.3.Market analysis, by country
4.2.4.Imaging devices
4.2.4.1.Market size and forecast
4.2.5.Dermatoscope
4.2.5.1.Market size and forecast
4.2.6.Microscope
4.2.6.1.Market size and forecast
4.3.Treatment devices
4.3.1.Key market trends, growth factors, and opportunities
4.3.2.Market size and forecast
4.3.3.Market analysis, by country
4.3.4.Electrosurgical devices
4.3.4.1.Market size and forecast
4.3.5.Cryotherapy devices
4.3.5.1.Market size and forecast
4.3.6.Laser devices
4.3.6.1.Market size and forecast
CHAPTER 5:DERMATOLOGY DEVICES MARKET, BY APPLICATION
5.1.Overview
5.1.1.Market size and forecast
5.2.Skin cancer diagnosis
5.2.1.Market size and forecast, by region
5.2.2.Market analysis, by country
5.3.Psoriasis
5.3.1.Market size and forecast, by region
5.3.2.Market analysis, by country
5.4.Skin rejuvenation
5.4.1.Market size and forecast, by region
5.4.2.Market analysis, by country
5.5.Warts
5.5.1.Market size and forecast, by region
5.5.2.Market analysis, by country
CHAPTER 6:DERMATOLOGY DEVICES MARKET, BY END USER
6.1.Overview
6.1.1.Market size and forecast
6.2.Hospitals
6.2.1.Market size and forecast, by region
6.2.2.Market analysis, by country
6.3.Clinics
6.3.1.Market size and forecast, by region
6.3.2.Market analysis, by country
6.4.Others
6.4.1.Market size and forecast, by region
6.4.2.Market analysis, by country
CHAPTER 7:DERMATOLOGY DEVICES MARKET, BY REGION
7.1.Overview
7.1.1.Market size and forecast
7.2.North America
7.2.1.Key market trends, growth factors, and opportunities
7.2.3.1.U.S.
7.2.3.1.1.U.S. dermatology devices market, by condition
7.2.3.1.2.U.S. dermatology devices market, by application
7.2.3.1.3.U.S. dermatology devices market, by end user
7.2.3.2.Canada
7.2.3.2.1.Canada dermatology devices market, by condition
7.2.3.2.2.Canada dermatology devices market, by application
7.2.3.2.3.Canada dermatology devices market, by end user
7.2.3.3.Mexico
7.2.3.3.1.Mexico dermatology devices market, by condition
7.2.3.3.2.Mexico dermatology devices market, by application
7.2.3.3.3.Mexico dermatology devices market, by end user
7.2.4.North America market size and forecast, by condition
7.2.5.North America market size and forecast, by application
7.2.6.North America market size and forecast, by end user
7.3.Europe
7.3.1.Key market trends, growth factors, and opportunities
7.3.2.Market size and forecast, by country
7.3.2.1.Germany
7.3.2.1.1.Germany dermatology devices market, by condition
7.3.2.1.2.Germany dermatology devices market, by application
7.3.2.1.3.Germany dermatology devices market, by end user
7.3.2.2.France
7.3.2.2.1.France dermatology devices market, by condition
7.3.2.2.2.France dermatology devices market, by application
7.3.2.2.3.France dermatology devices market, by end user
7.3.2.3.UK
7.3.2.3.1.UK dermatology devices market, by condition
7.3.2.3.2.UK dermatology devices market, by application
7.3.2.3.3.UK dermatology devices market, by end user
7.3.2.4.Italy
7.3.2.4.1.Italy dermatology devices market, by condition
7.3.2.4.2.Italy dermatology devices market, by application
7.3.2.4.3.Italy dermatology devices market, by end user
7.3.2.5.Spain
7.3.2.5.1.Spain dermatology devices market, by condition
7.3.2.5.2.Spain dermatology devices market, by application
7.3.2.5.3.Spain dermatology devices market, by end user
7.3.2.6.Rest of Europe
7.3.2.6.1.Rest of Europe dermatology devices market, by condition
7.3.2.6.2.Rest of Europe dermatology devices market, by application
7.3.2.6.3.Rest of Europe dermatology devices market, by end user
7.3.3.Europe market size and forecast, by condition
7.3.4.Europe market size and forecast, by application
7.3.5.Europe market size and forecast, by end user
7.4.Asia-Pacific
7.4.1.Key market trends, growth factors, and opportunities
7.4.2.Market size and forecast, by country
7.4.2.1.Japan
7.4.2.1.1.Japan dermatology devices market, by condition
7.4.2.1.2.Japan dermatology devices market, by application
7.4.2.1.3.Japan dermatology devices market, by end user
7.4.2.2.China
7.4.2.2.1.China dermatology devices market, by condition
7.4.2.2.2.China dermatology devices market, by application
7.4.2.2.3.China dermatology devices market, by end user
7.4.2.3.Australia
7.4.2.3.1.Australia dermatology devices market, by condition
7.4.2.3.2.Australia dermatology devices market, by application
7.4.2.3.3.Australia dermatology devices market, by end user
7.4.2.4.India
7.4.2.4.1.India dermatology devices market, by condition
7.4.2.4.2.India dermatology devices market, by application
7.4.2.4.3.India dermatology devices market, by end user
7.4.2.5.South Korea
7.4.2.5.1.South Korea dermatology devices market, by condition
7.4.2.5.2.South Korea dermatology devices market, by application
7.4.2.5.3.South Korea dermatology devices market, by end user
7.4.2.6.Rest of Asia-Pacific
7.4.2.6.1.Rest of Asia-Pacific dermatology devices market, by condition
7.4.2.6.2.Rest of Asia-Pacific dermatology devices market, by application
7.4.2.6.3.Rest of Asia-Pacific dermatology devices market, by end user
7.4.3.Asia-Pacific market size and forecast, by condition
7.4.4.Asia-Pacific market size and forecast, by application
7.4.5.Asia-Pacific market size and forecast, by end user
7.5.LAMEA
7.5.1.Key market trends, growth factors, and opportunities
7.5.2.Market size and forecast, by country
7.5.2.1.Brazil
7.5.2.1.1.Brazil dermatology devices market, by condition
7.5.2.1.2.Brazil dermatology devices market, by application
7.5.2.1.3.Brazil dermatology devices market, by end user
7.5.2.2.Saudi Arabia
7.5.2.2.1.Saudi Arabia dermatology devices market, by condition
7.5.2.2.2.Saudi Arabia dermatology devices market, by application
7.5.2.2.3.Saudi Arabia dermatology devices market, by end user
7.5.2.3.South Africa
7.5.2.3.1.South Africa dermatology devices market, by condition
7.5.2.3.2.South Africa dermatology devices market, by application
7.5.2.3.3.South Africa dermatology devices market, by end user
7.5.2.4.Rest of LAMEA
7.5.2.4.1.Rest of LAMEA dermatology devices market, by condition
7.5.2.4.2.Rest of LAMEA dermatology devices market, by application
7.5.2.4.3.Rest of LAMEA dermatology devices market, by end user
7.5.3.LAMEA market size and forecast, by condition
7.5.4.LAMEA market size and forecast, by application
7.5.5.LAMEA market size and forecast, by end user
CHAPTER 8:COMPANY PROFILES
8.1.ALMA LASERS LTD.
8.1.1.Company overview
8.1.2.Company snapshot
8.1.3.Operating business segments
8.1.4.Product portfolio
8.2.AMBICARE HEALTH LTD
8.2.1.Company overview
8.2.2.Company snapshot
8.2.3.Product portfolio
8.3.BAUSCH HEALTH COMPANIES INC.
8.3.1.Company overview
8.3.2.Company snapshot
8.3.3.Operating business segments
8.3.4.Product portfolio
8.3.5.Business performance
8.3.6.Key strategic moves and developments
8.4.CANDELA LASER CORP
8.4.1.Company overview
8.4.2.Company snapshot
8.4.3.Operating business segments
8.4.4.Product portfolio
8.5.CANFIELD SCIENTIFIC, INC
8.5.1.Company overview
8.5.2.Company snapshot
8.5.3.Operating business segments
8.5.4.Product portfolio
8.5.5.Key strategic moves and developments
8.6.CARL ZEISS MEDITEC AG
8.6.1.Company overview
8.6.2.Company snapshot
8.6.3.Operating business segments
8.6.4.Product portfolio
8.6.5.Business performance
8.7.CUTERA, INC.
8.7.1.Company overview
8.7.2.Company snapshot
8.7.3.Operating business segments
8.7.4.Product portfolio
8.7.5.Business performance
8.7.6.Key strategic moves and developments
8.8.CYNOSURE, INC.
8.8.1.Company overview
8.8.2.Company snapshot
8.8.3.Operating business segments
8.8.4.Product portfolio
8.9.HEINE OPTOTECHNIK
8.9.1.Company overview
8.9.2.Company snapshot
8.9.3.Product portfolio
8.10.LUMENIS LTD.
8.10.1.Company overview
8.10.2.Company snapshot
8.10.3.Operating business segments
8.10.4.Product portfolio
8.10.5.Key strategic moves and developments
TABLE 01.DERMATOLOGY DEVICES MARKET, BY PRODUCT, 2020-2030 ($MILLION)
TABLE 02.DERMATOLOGY DEVICES MARKET FOR DIAGNOSTIC DEVICES, BY REGION, 2020-2030 ($MILLION)
TABLE 03.DERMATOLOGY DEVICES MARKET FOR TREATMENT DEVICES, BY REGION, 2020-2030 ($MILLION)
TABLE 04.DERMATOLOGY DEVICES MARKET, BY APPLICATION, 2020-2030 ($MILLION)
TABLE 05.DERMATOLOGY DEVICES MARKET FOR SKIN CANCER DIAGNOSIS, BY REGION, 2020-2030 ($MILLION)
TABLE 06.DERMATOLOGY DEVICES MARKET FOR PSORIASIS, BY REGION, 2020-2030 ($MILLION)
TABLE 07.DERMATOLOGY DEVICES MARKET FOR SKIN REJUVENATION, BY REGION, 2020-2030 ($MILLION)
TABLE 08.DERMATOLOGY DEVICES MARKET FOR WARTS, BY REGION, 2020-2030 ($MILLION)
TABLE 09.DERMATOLOGY DEVICES MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 10.DERMATOLOGY DEVICES MARKET FOR HOSPITALS, BY REGION, 2020-2030 ($MILLION)
TABLE 11.DERMATOLOGY DEVICES MARKET FOR CLINICS, BY REGION, 2020-2030 ($MILLION)
TABLE 12.DERMATOLOGY DEVICES MARKET FOR OTHERS, BY REGION, 2020-2030 ($MILLION)
TABLE 13.DERMATOLOGY DEVICES MARKET, BY REGION, 2020–2030 ($MILLION)
TABLE 16.U.S. DERMATOLOGY DEVICES MARKET, BY PRODUCT, 2020–2030 ($MILLION)
TABLE 17.U.S. DERMATOLOGY DEVICES MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 18.U.S. DERMATOLOGY DEVICES MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 19.CANADA DERMATOLOGY DEVICES MARKET, BY PRODUCT, 2020–2030 ($MILLION)
TABLE 20.CANADA DERMATOLOGY DEVICES MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 21.CANADA DERMATOLOGY DEVICES MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 22.MEXICO DERMATOLOGY DEVICES MARKET, BY PRODUCT, 2020–2030 ($MILLION)
TABLE 23.MEXICO DERMATOLOGY DEVICES MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 24.MEXICO DERMATOLOGY DEVICES MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 25.NORTH AMERICA DERMATOLOGY DEVICES MARKET, BY PRODUCT, 2020–2030 ($MILLION)
TABLE 26.NORTH AMERICA DERMATOLOGY DEVICES MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 27.NORTH AMERICA DERMATOLOGY DEVICES MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 28.EUROPE DERMATOLOGY DEVICES MARKET, BY COUNTRY, 2020–2030 ($MILLION)
TABLE 29.GERMANY DERMATOLOGY DEVICES MARKET, BY PRODUCT, 2020–2030 ($MILLION)
TABLE 30.GERMANY DERMATOLOGY DEVICES MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 31.GERMANY DERMATOLOGY DEVICES MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 32.FRANCE DERMATOLOGY DEVICES MARKET, BY PRODUCT, 2020–2030 ($MILLION)
TABLE 33.FRANCE DERMATOLOGY DEVICES MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 34.FRANCE DERMATOLOGY DEVICES MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 35.UK DERMATOLOGY DEVICES MARKET, BY PRODUCT, 2020–2030 ($MILLION)
TABLE 36.UK DERMATOLOGY DEVICES MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 37.UK DERMATOLOGY DEVICES MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 38.ITALY DERMATOLOGY DEVICES MARKET, BY PRODUCT, 2020–2030 ($MILLION)
TABLE 39.ITALY DERMATOLOGY DEVICES MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 40.ITALY DERMATOLOGY DEVICES MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 41.SPAIN DERMATOLOGY DEVICES MARKET, BY PRODUCT, 2020–2030 ($MILLION)
TABLE 42.SPAIN DERMATOLOGY DEVICES MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 43.SPAIN DERMATOLOGY DEVICES MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 44.REST OF EUROPE DERMATOLOGY DEVICES MARKET, BY PRODUCT, 2020–2030 ($MILLION)
TABLE 45.REST OF EUROPE DERMATOLOGY DEVICES MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 46.REST OF EUROPE DERMATOLOGY DEVICES MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 47.EUROPE DERMATOLOGY DEVICES MARKET, BY PRODUCT, 2020–2030 ($MILLION)
TABLE 48.EUROPE DERMATOLOGY DEVICES MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 49.EUROPE DERMATOLOGY DEVICES MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 50.ASIA-PACIFIC DERMATOLOGY DEVICES MARKET, BY COUNTRY, 2020–2030 ($MILLION)
TABLE 51.JAPAN DERMATOLOGY DEVICES MARKET, BY PRODUCT, 2020–2030 ($MILLION)
TABLE 52.JAPAN DERMATOLOGY DEVICES MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 53.JAPAN DERMATOLOGY DEVICES MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 54.CHINA DERMATOLOGY DEVICES MARKET, BY PRODUCT, 2020–2030 ($MILLION)
TABLE 55.CHINA DERMATOLOGY DEVICES MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 56.CHINA DERMATOLOGY DEVICES MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 57.AUSTRALIA DERMATOLOGY DEVICES MARKET, BY PRODUCT, 2020–2030 ($MILLION)
TABLE 58.AUSTRALIA DERMATOLOGY DEVICES MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 59.AUSTRALIA DERMATOLOGY DEVICES MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 60.INDIA DERMATOLOGY DEVICES MARKET, BY PRODUCT, 2020–2030 ($MILLION)
TABLE 61.INDIA DERMATOLOGY DEVICES MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 62.INDIA DERMATOLOGY DEVICES MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 63.SOUTH KOREA DERMATOLOGY DEVICES MARKET, BY PRODUCT, 2020–2030 ($MILLION)
TABLE 64.SOUTH KOREA DERMATOLOGY DEVICES MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 65.SOUTH KOREA DERMATOLOGY DEVICES MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 66.REST OF ASIA-PACIFIC DERMATOLOGY DEVICES MARKET, BY PRODUCT, 2020–2030 ($MILLION)
TABLE 67.REST OF ASIA-PACIFIC DERMATOLOGY DEVICES MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 68.REST OF ASIA-PACIFIC DERMATOLOGY DEVICES MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 69.ASIA-PACIFIC DERMATOLOGY DEVICES MARKET, BY PRODUCT, 2020–2030 ($MILLION)
TABLE 70.ASIA-PACIFIC DERMATOLOGY DEVICES MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 71.ASIA-PACIFIC DERMATOLOGY DEVICES MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 72.LAMEA DERMATOLOGY DEVICES MARKET, BY COUNTRY, 2020–2030 ($MILLION)
TABLE 73.BRAZIL DERMATOLOGY DEVICES MARKET, BY PRODUCT, 2020–2030 ($MILLION)
TABLE 74.BRAZIL DERMATOLOGY DEVICES MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 75.BRAZIL DERMATOLOGY DEVICES MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 76.SAUDI ARABIA DERMATOLOGY DEVICES MARKET, BY PRODUCT, 2020–2030 ($MILLION)
TABLE 77.SAUDI ARABIA DERMATOLOGY DEVICES MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 78.SAUDI ARABIA DERMATOLOGY DEVICES MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 79.SOUTH AFRICA DERMATOLOGY DEVICES MARKET, BY PRODUCT, 2020–2030 ($MILLION)
TABLE 80.SOUTH AFRICA DERMATOLOGY DEVICES MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 81.SOUTH AFRICA DERMATOLOGY DEVICES MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 82.REST OF LAMEA DERMATOLOGY DEVICES MARKET, BY PRODUCT, 2020–2030 ($MILLION)
TABLE 83.REST OF LAMEA DERMATOLOGY DEVICES MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 84.REST OF LAMEA DERMATOLOGY DEVICES MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 85.LAMEA DERMATOLOGY DEVICES MARKET, BY PRODUCT, 2020–2030 ($MILLION)
TABLE 86.LAMEA DERMATOLOGY DEVICES MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 87.LAMEA DERMATOLOGY DEVICES MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 88.ALMA LASERS: COMPANY SNAPSHOT
TABLE 89.ALMA LASERS: OPERATING SEGMENTS
TABLE 90.ALMA LASERS: PRODUCT PORTFOLIO
TABLE 91.AMBICARE HEALTH: COMPANY SNAPSHOT
TABLE 92.AMBICARE HEALTH: PRODUCT TYPE PORTFOLIO
TABLE 93.BAUSCH HEALTH: COMPANY SNAPSHOT
TABLE 94.BAUSCH HEALTH: OPERATING SEGMENTS
TABLE 95.BAUSCH HEALTH: PRODUCT PORTFOLIO
TABLE 96.CANDELA: COMPANY SNAPSHOT
TABLE 97.CANDELA: OPERATING SEGMENTS
TABLE 98.CANDELA: PRODUCT TYPE PORTFOLIO
TABLE 99.CANFIELD SCIENTIFIC.: COMPANY SNAPSHOT
TABLE 100.CANFIELD SCIENTIFIC: OPERATING SEGMENTS
TABLE 101.CANFIELD SCIENTIFIC: PRODUCT TYPE PORTFOLIO
TABLE 102.CARL ZEISS: COMPANY SNAPSHOT
TABLE 103.CARL ZEISS: OPERATING SEGMENTS
TABLE 104.CARL ZEISS: PRODUCT PORTFOLIO
TABLE 105.CUTERA INC: COMPANY SNAPSHOT
TABLE 106.CUTERA, INC.: OPERATING SEGMENTS
TABLE 107.CUTERA, INC.: PRODUCT PORTFOLIO
TABLE 108.CYNOSURE, INC.: COMPANY SNAPSHOT
TABLE 109.CYNOSURE, INC.: OPERATING SEGMENTS
TABLE 110.CYNOSURE, INC.: PRODUCT PORTFOLIO
TABLE 111.HEINE OPTOTECHNIK: COMPANY SNAPSHOT
TABLE 112.HEINE OPTOTECHNIK: PRODUCT TYPE PORTFOLIO
TABLE 113.LUMENIS LTD: COMPANY SNAPSHOT
TABLE 114.LUMENIS LTD: OPERATING SEGMENTS
TABLE 115.LUMENIS LTD: PRODUCT PORTFOLIO
Complete report $6,100. DataPack (test volumes, sales forecasts, supplier shares) $3,950.
Summary
This comprehensive report contains 409 pages, 35 tables, and is designed to help current suppliers and potential market entrants identify and evaluate business opportunities emerging in the UK coagulation testing market duri...
Complete report $9,600. DataPack (test volumes, sales forecasts, supplier shares) $6,200.
Summary
This comprehensive report contains 424 pages, 37 tables, and is designed to help current suppliers and potential market entrants identify and evaluate business opportunities emerging in the US coagulation testing market during the...
This new report from VPGMarketResearch.com provides strategic assessments of major blood banking product suppliers and emerging market entrants. The report presents analyses of major current and emerging suppliers in terms of their sales, market shares, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements, and business strategies.
Con...